Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker

6 Apr 2022

Abstract excerpt

To investigate aldo-keto reductase 1C3 (AKR1C3) expression in T and B acute lymphoblastic leukemia/lymphoma (ALL) patients. Three commercial antibodies were evaluated for AKR1C3 immunohistochemistry (IHC) staining performance: Polyclonal Thermofisher scientific (Clone#PA523667), rabbit monoclonal Abcam [EPR16726] (ab209899) and Sigma/Millipore anti-AKR1C3 antibody, mouse monoclonal, clone NP6.G6.A6, purified from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Aldose Reductase and Taurine
Share to Childhood Cancer Survivors' Quality of Life

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35388063
DOI: 10.1038/s41598-022-09697-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarkerPMID 35388063Read ↗

AKR1C3 Expression in T and B Acute Lymphoblastic Leukemia/Lymphoma for Clinical Use as a BiomarkerSemantic proximity Read ↗

AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemiaSemantic proximity Read ↗

AKR1C enzymes sustain therapy resistance in paediatric T-ALLSemantic proximity Read ↗

AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsSemantic proximity Read ↗

Adult B-Cell Acute Lymphoblastic Leukaemia Antigens and Enriched Pathways Identify New Targets for TherapySemantic proximity Read ↗

Harnessing ALDH1A2 vulnerability in T-cell acute lymphoblastic leukemiaSemantic proximity Read ↗

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteinsSemantic proximity Read ↗

TP53 isoform dysregulation in pediatric B-ALL: identifying markers of favorable prognosis and relapse-associated dynamic.Semantic proximity Read ↗

Establishment and chacterization of a novel cell line ICH-BCPALL-3 from B-cell precursor acute lymphoblastic leukemia with TCF3::HLF.Semantic proximity Read ↗

PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1 -like acute lymphoblastic leukaemia in Indian patientsSemantic proximity Read ↗

An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse.Semantic proximity Read ↗

BRD4 PROTAC Degrader ARV-825 Inhibits T-Cell Acute Lymphoblastic Leukemia by Targeting 'Undruggable' Myc-pathway GenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.